Pancreatic Ductal Adenocarcinoma Latest Advances
Find the Latest Research About Pancreatic Ductal Adenocarcinoma
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7500 publications
ASO Visual Abstract: Neoadjuvant Chemoradiotherapy versus Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Journal: Annals of surgical oncology
Published: September 03, 2026
Targeting CTGF+ cancer-associated fibroblasts disrupts tumor-stroma crosstalk in pancreatic ductal adenocarcinoma.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 02, 2026
Machine Learning-Based Identification of Survival-Associated CpG Biomarkers in Pancreatic Ductal Adenocarcinoma.
Journal: Journal of precision medicine (Amsterdam, Netherlands)
Published: September 01, 2026
Correction: Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medium term in nationwide electronic health records of primary care physicians.
Journal: British journal of cancer
Published: August 31, 2026
Neoadjuvant Chemotherapy With or Without Radiotherapy in Resected Pancreatic Ductal Adenocarcinoma.
Journal: JAMA surgery
Published: August 26, 2026
Development of a mobile high-intensity focused ultrasound platform for preclinical tumor microenvironment modulation in a pancreatic ductal adenocarcinoma mouse model.
Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
Published: August 18, 2026
Alliance A022106: A Phase II/III Trial of Nab-Paclitaxel and Gemcitabine ± Cisplatin as Second-Line Treatment for BRCA1/2 or PALB2 Mutant Metastatic Pancreatic Ductal Adenocarcinoma (PLATINUM).
Journal: JCO oncology advances
Published: August 18, 2026
Precision pain management in pancreatic ductal adenocarcinoma: therapeutic progress and mechanism-based approaches targeting tumor-nerve-immune crosstalk
Journal: Zhonghua yi xue za zhi
Published: August 13, 2026
7-Dehydrocholesterol-mediated ferroptosis is governed by glucose availability in pancreatic ductal adenocarcinoma.
Journal: Acta biochimica et biophysica Sinica
Published: August 12, 2026
METTL1-mediated m7G modification of valine tRNAs drives metabolic adaptation in pancreatic ductal adenocarcinoma.
Journal: The Journal of clinical investigation
Published: August 11, 2026
ASO Visual Abstract: Association of Cancer Center Designation with Multimodality Treatment, Perioperative Outcomes, and Survival Among Older Adults with Pancreatic Ductal Adenocarcinoma.
Journal: Annals of surgical oncology
Published: August 10, 2026
Daraxonrasib: A Breakthrough in Pancreatic Ductal Adenocarcinoma.
Journal: Cureus
Published: August 03, 2026
Last Updated: 09/26/2026